Eleonora Teplinsky: The POSITIVE Trial SABCS23 updates are so important to help with oncofertility counseling
Eleonora Teplinsky shared on X/Twitter:
“The POSITIVE Trial SABCS23 updates are so important to help with oncofertility counseling.
1) 94% of patients who reported amenorrhea at time of enrollment recovered menses and most during the first 6 months.
2) Younger age correlated to a shorter time to pregnancy. The use of chemotherapy, addition of GnRH agonists (Lupron/Zoladex), prior endocrine therapy, prior birth, menstrual status at time of enrollment did not impact time to pregnancy.
3) Embryo/oocyte cryopreservation at BC diagnosis, embryo transfer after endocrine therapy interruption had higher pregnancy rates and not associated with worse prognosis.
4) No increase in breast cancer events in patients undergoing IVF on study.”
Source: Eleonora Teplinsky/X
Eleonora Teplinsky is a medical oncologist specializing in breast and gynecologic oncology. She is the head of breast and gynecological medical oncology at Valley-Mount Sinai Comprehensive Cancer Care in Paramus, New Jersey, and a clinical assistant professor of medicine at the Icahn School of Medicine at Mount Sinai in New York.
Her clinical and research interests focus on young women with breast cancer, survivorship, exercise oncology, and the use of social media in oncology. She is passionate about oncology education and advocacy on social media and is the host of the INTERLUDE Podcast, where she shares the stories and experiences of those who have been affected by cancer.
Dr. Teplinsky is the co-lead of the The Collaboration for Outcomes using Social Media in Oncology (COSMO) – a social media lab working to provide a venue for social media research in oncology.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023